BioArctic AB (publ) (STO:BIOA.B)
336.80
-1.59 (-0.47%)
At close: May 28, 2026
BioArctic AB Employees
BioArctic AB had 129 employees as of December 31, 2025. The number of employees increased by 22 or 20.56% compared to the previous year.
Employees
129
Change
22
Growth
20.56%
Revenue / Employee
8.14M SEK
Profits / Employee
1.51M SEK
Market Cap
30.20B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 129 | 22 | 20.56% |
| Sep 30, 2025 | 122 | 18 | 17.31% |
| Jun 30, 2025 | 119 | 23 | 23.96% |
| Mar 31, 2025 | 116 | 26 | 28.89% |
| Dec 31, 2024 | 107 | 19 | 21.59% |
| Sep 30, 2024 | 104 | 21 | 25.30% |
| Jun 30, 2024 | 96 | 21 | 28.00% |
| Mar 31, 2024 | 90 | 21 | 30.43% |
| Dec 31, 2023 | 88 | 27 | 44.26% |
| Sep 30, 2023 | 83 | 27 | 48.21% |
| Jun 30, 2023 | 75 | 19 | 33.93% |
| Mar 31, 2023 | 69 | 14 | 25.45% |
| Dec 31, 2022 | 61 | 12 | 24.49% |
| Sep 30, 2022 | 56 | 7 | 14.29% |
| Jun 30, 2022 | 56 | 9 | 19.15% |
| Mar 31, 2022 | 55 | 8 | 17.02% |
| Dec 31, 2021 | 49 | 4 | 8.89% |
| Sep 30, 2021 | 49 | 4 | 8.89% |
| Jun 30, 2021 | 47 | 2 | 4.44% |
| Mar 31, 2021 | 47 | 4 | 9.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Camurus AB | 285 |
| Hansa Biopharma AB | 122 |
| BioInvent International AB | 112 |
| Egetis Therapeutics AB | 44 |
| Vicore Pharma Holding AB | 37 |
| Genovis AB (publ.) | 36 |
| Saniona AB | 31 |
| Xspray Pharma AB | 24 |
BioArctic AB News
- 3 days ago - BioArctic's partner Eisai presents sales simulation of potential future sales of Leqembi® at its Investor Relations Day - PRNewsWire
- 8 days ago - BioArctic Interim Report for the period January - March 2026 - PRNewsWire
- 8 days ago - BioArctic AB Earnings Call Transcript: Q1 2026 - Transcripts
- 8 days ago - BioArctic AB Quarterly report: Q1 2026 - Filings
- 8 days ago - BioArctic AB Slides: Q1 2026 - Filings
- 15 days ago - Invitation to presentation of BioArctic's first quarter report for January - March 2026 on May 20 at 9:30 a.m. CET - PRNewsWire
- 20 days ago - Leqembi® Iqlik™ PDUFA date updated to August 24 in the U.S. - PRNewsWire
- 5 weeks ago - BioArctic publishes the Annual Report and Sustainability Report for 2025 - PRNewsWire